标普生物科技LOF(161127)
动态评分： 5.42分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2020-06-30 | TGTX | TG Therapeutics Inc | 109.15 | 1.05% |
| 2020-06-30 | BPMC | Blueprint Medicines Corp | 107.51 | 1.04% |
| 2020-06-30 | FATE | Fate Therapeutics Inc | 107.48 | 1.04% |
| 2020-06-30 | MRTX | Mirati Therapeutics Inc | 107.42 | 1.04% |
| 2020-06-30 | BCRX | BioCryst Pharmaceuticals Inc | 106.98 | 1.03% |
| 2020-06-30 | BHVN | Biohaven Pharmaceutical Holding Co Ltd | 106.73 | 1.03% |
| 2020-06-30 | CHRS | Coherus BioSciences Inc | 106.98 | 1.03% |
| 2020-06-30 | DCPH | Deciphera Pharmaceuticals Inc | 106.08 | 1.02% |
| 2020-06-30 | AMGN | 安进 | 104.36 | 1.01% |
| 2020-06-30 | MNTA | Momenta Pharmaceuticals Inc | 103.21 | 1% |
| 2020-06-30 | VRTX | 福泰制药 | 104.2 | 1% |
| 2020-06-30 | ABBV | 艾伯维 | 102.31 | 0.99% |
| 2020-06-30 | FGEN | FibroGen Inc | 102.32 | 0.99% |
| 2020-06-30 | NBIX | 神经分泌生物科学 | 102.35 | 0.99% |
| 2020-06-30 | REGN | 再生元制药 | 102.43 | 0.99% |
| 2020-06-30 | ACAD | 阿卡迪亚 | 101.84 | 0.98% |
| 2020-06-30 | APLS | Apellis Pharmaceuticals Inc | 101.55 | 0.98% |
| 2020-06-30 | EXEL | 伊克力西斯 | 102.13 | 0.98% |
| 2020-06-30 | GILD | 吉利德科学 | 101.26 | 0.98% |
| 2020-06-30 | UTHR | 联合治疗 | 101 | 0.97% |
公告&资料